Carmen Salaverria1, Nuria Rossell1,2, Angelica Hernandez1, Soad Fuentes Alabi1, Roberto Vasquez1, Miguel Bonilla3, Catherine G Lam3,4,5, Raul C Ribeiro4,5. 1. Department of Oncology, Benjamin Bloom Hospital, San Salvador, El Salvador. 2. Amsterdam Institute for Social Sciences Research (AISSR), Amsterdam University, the Netherlands. 3. International Outreach Program, St. Jude Children's Research Hospital, Memphis, Tenesse. 4. Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tenesse. 5. University of Tennessee, College of Medicine, Memphis, Tenesse.
Abstract
BACKGROUND: In El Salvador, about 200 new cases of pediatric cancer are diagnosed each year, and survival rates approach 70%. Although treatment is available at no cost, abandonment of therapy has remained at a steady yearly rate of 13% during the past decade. A time sensitive adherence tracking procedure (TS-ATP) was recently implemented to detect missed appointments, identify their causes, and intervene promptly. Procedure The study team was informed daily of patient/family failure to attend medical appointments in the pediatric oncology unit; the families were contacted and interviewed to ascertain and address the reasons. Patients who did not return after this initial contact were contacted again through local health clinics and municipalities. Law enforcement was a last resort for patients undergoing frontline treatment with a good prognosis., The system was adapted to clinical urgency: families of patients undergoing induction therapy were contacted within 24 hr, those in other therapy phases, within 48 hr, and those who had completed treatment, within one week. Reasons for absence were obtained by telephone or in person. RESULTS: The annual rate of abandonment was reduced from 13-3% during the 2 years period. There were 1,111 absences reported and 1,472 contacts with caregivers and institutions. The three main reasons for absences were financial needs (165, 23%), unforeseen barriers (116, 16%), and domestic needs (86, 12%). CONCLUSIONS: Use of the treatment adherence tracking system to locate and communicate with patients/families after missed appointments and the allocated aid stemming from these interviews substantially reduced abandonment and non-adherence.
BACKGROUND: In El Salvador, about 200 new cases of pediatric cancer are diagnosed each year, and survival rates approach 70%. Although treatment is available at no cost, abandonment of therapy has remained at a steady yearly rate of 13% during the past decade. A time sensitive adherence tracking procedure (TS-ATP) was recently implemented to detect missed appointments, identify their causes, and intervene promptly. Procedure The study team was informed daily of patient/family failure to attend medical appointments in the pediatric oncology unit; the families were contacted and interviewed to ascertain and address the reasons. Patients who did not return after this initial contact were contacted again through local health clinics and municipalities. Law enforcement was a last resort for patients undergoing frontline treatment with a good prognosis., The system was adapted to clinical urgency: families of patients undergoing induction therapy were contacted within 24 hr, those in other therapy phases, within 48 hr, and those who had completed treatment, within one week. Reasons for absence were obtained by telephone or in person. RESULTS: The annual rate of abandonment was reduced from 13-3% during the 2 years period. There were 1,111 absences reported and 1,472 contacts with caregivers and institutions. The three main reasons for absences were financial needs (165, 23%), unforeseen barriers (116, 16%), and domestic needs (86, 12%). CONCLUSIONS: Use of the treatment adherence tracking system to locate and communicate with patients/families after missed appointments and the allocated aid stemming from these interviews substantially reduced abandonment and non-adherence.
Authors: S Brown; A Belgaumi; A Kofide; R Sabbah; A Ezzat; B Littlechild; M Shoukri; R Barr; A Levin Journal: Eur J Cancer Care (Engl) Date: 2008-12-08 Impact factor: 2.520
Authors: Saskia Mostert; Stefanus Gunawan; Emma Wolters; Peter van de Ven; Mei Sitaresmi; Josephine van Dongen; Anjo Veerman; Max Mantik; Gertjan Kaspers Journal: Asian Pac J Cancer Prev Date: 2012
Authors: Monika L Metzger; Scott C Howard; Ligia C Fu; Armando Peña; Rene Stefan; Michael L Hancock; Zhe Zhang; Ching Hon Pui; Judy Wilimas; Raul C Ribeiro Journal: Lancet Date: 2003-08-30 Impact factor: 79.321
Authors: Peter F Coccia; Jessica Altman; Smita Bhatia; Scott C Borinstein; Joseph Flynn; Suzanne George; Robert Goldsby; Robert Hayashi; Mary S Huang; Rebecca H Johnson; Lynda Kwon Beaupin; Michael P Link; Kevin C Oeffinger; Kathleen M Orr; Alberto S Pappo; Damon Reed; Holly L Spraker; Deborah A Thomas; Margaret von Mehren; Daniel S Wechsler; Kimberly F Whelan; Bradley J Zebrack; Hema Sundar; Dorothy A Shead Journal: J Natl Compr Canc Netw Date: 2012-09 Impact factor: 11.908
Authors: Soad Fuentes-Alabi; Nickhill Bhakta; Roberto Franklin Vasquez; Sumit Gupta; Susan E Horton Journal: Cancer Date: 2017-09-15 Impact factor: 6.860
Authors: Laura Rodriguez-Romo; Alberto Olaya Vargas; Sumit Gupta; Jaime Shalkow-Klincovstein; Lourdes Vega-Vega; Alfonso Reyes-Lopez; Carlo Cicero-Oneto; Juan Mejia-Arangure; Oscar Gonzalez-Ramella; Rafael Pineiro-Retif; Aracely Lopez-Facundo; Maria de Los Angeles Del Campo-Martinez; Isidoro Tejocote; Kelly Brennan; Christopher M Booth Journal: J Glob Oncol Date: 2018-07